Want to see IN:SUMICHEM full AI Analyst Report?
Top Page
Sumitomo Chemical India Ltd.
(SUMICHEM)
Select Model
Select Model
Rating:71Outperform
Price Target:
₹610.00
▲(30.16% Upside)
Action:Reiterated
Date:07/04/26
The score is primarily supported by strong financial fundamentals—especially very low leverage and resilient profitability—tempered by uneven cash-flow conversion and cyclical/volatile revenue. Technically, the stock is trading above major moving averages, but mixed momentum (negative MACD) limits conviction. The largest drag is valuation, with a high P/E and low dividend yield.
Positive Factors
Very Low Leverage
A highly conservative capital structure limits interest and refinancing risk, preserving resilience through agricultural cycles. The growing equity base also gives Sumitomo Chemical India financial flexibility to sustain operations and fund measured expansion.
Negative Factors
Revenue Growth Volatility
Uneven revenue performance shows exposure to crop cycles, pricing, seasonal demand, and agricultural conditions. Repeated down years can limit operating leverage and make sustained earnings growth less predictable even when margins remain resilient.
Read all positive and negative factors
Positive Factors
Negative Factors
Very Low Leverage
A highly conservative capital structure limits interest and refinancing risk, preserving resilience through agricultural cycles. The growing equity base also gives Sumitomo Chemical India financial flexibility to sustain operations and fund measured expansion.
Read all positive factors
Sumitomo Chemical India Ltd. (SUMICHEM) vs. iShares MSCI India ETF (INDA)
Market Cap
₹261.03B
Dividend Yield0.25%
Average Volume (3M)14.60K
Price to Earnings (P/E)44.6
Beta (1Y)1.17
Revenue Growth-3.61%
EPS Growth4.00%
CountryIN
Employees1,622
SectorGeneral
Sector StrengthN/A
IndustryAgricultural Inputs
Share Statistics
EPS (TTM)10.88
Shares Outstanding499,145,720
10 Day Avg. Volume20,149
30 Day Avg. Volume14,601
Financial Highlights & Ratios
PEG Ratio4.52
Price to Book (P/B)5.37
Price to Sales (P/S)5.62
P/FCF Ratio38.07
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)13
Revenue Forecast (FY)₹35.81B
Sumitomo Chemical India Ltd. Business Overview & Revenue Model
Company Description
Sumitomo Chemical India Limited (SCIL) specializes in the global production and distribution of a diverse array of chemical products. Its core business encompasses the manufacture and sale of insecticides for household and public health use, agric...
How the Company Makes Money
SUMICHEM makes money primarily by selling crop protection products and related agricultural inputs. Revenue is generated from (1) sales of formulated/branded crop protection products (e.g., insecticides, herbicides, fungicides) marketed through ag...
Sumitomo Chemical India Ltd. Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
92
Very Positive
Cash Flow
67
Positive
| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 32.38B | 31.49B | 28.44B | 35.11B | 30.61B |
| Gross Profit | 10.21B | 12.70B | 10.49B | 12.24B | 11.36B |
| EBITDA | 8.02B | 6.10B | 4.53B | 6.47B | 5.82B |
| Net Income | 5.43B | 5.05B | 3.70B | 5.02B | 4.24B |
Balance Sheet | |||||
| Total Assets | 44.74B | 39.64B | 33.13B | 33.69B | 30.10B |
| Cash, Cash Equivalents and Short-Term Investments | 10.08B | 12.59B | 8.91B | 5.63B | 5.75B |
| Total Debt | 633.00M | 518.93M | 302.49M | 339.72M | 375.84M |
| Total Liabilities | 10.80B | 10.59B | 8.69B | 9.87B | 10.82B |
| Stockholders Equity | 33.90B | 29.01B | 24.42B | 23.82B | 19.27B |
Cash Flow | |||||
| Free Cash Flow | 4.78B | 4.87B | 6.93B | 2.70B | 1.08B |
| Operating Cash Flow | 5.22B | 5.17B | 7.57B | 3.89B | 2.22B |
| Investing Cash Flow | -4.08B | -4.57B | -4.20B | -3.27B | -2.90B |
| Financing Cash Flow | -828.79M | -679.20M | -3.37B | -725.45M | -626.38M |
Sumitomo Chemical India Ltd. Technical Analysis
Positive
468.65
Price Trends
510.17
Positive
482.72
Positive
455.62
Positive
Market Momentum
2.83
Positive
45.07
Neutral
12.63
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:SUMICHEM, the sentiment is Positive. The current price of 468.65 is below the 20-day moving average (MA) of 537.35, below the 50-day MA of 510.17, and above the 200-day MA of 455.62, indicating a neutral trend. The MACD of 2.83 indicates Positive momentum. The RSI at 45.07 is Neutral, neither overbought nor oversold. The STOCH value of 12.63 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:SUMICHEM.
Sumitomo Chemical India Ltd. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ₹40.90B | 19.07 | ― | 1.37% | 4.41% | 24.42% | |
71 Outperform | ₹261.03B | 44.60 | ― | 0.26% | -3.61% | 4.00% | |
71 Outperform | ₹71.58B | 11.29 | ― | 1.84% | 18.52% | 49.11% | |
68 Neutral | ₹182.76B | 24.85 | ― | 2.96% | -2.78% | 23.56% | |
58 Neutral | ₹490.34B | 23.86 | ― | 0.77% | 12.86% | 72.26% | |
56 Neutral | ₹375.96B | 31.51 | ― | 0.49% | -16.57% | -27.71% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
IN:SUMICHEM
Sumitomo Chemical India Ltd.
517.85
-48.73
-8.60%
IN:BAYERCROP
Bayer Cropscience India Limited
4,050.20
-1,005.43
-19.89%
IN:PIIND
PI Industries Limited
2,430.00
-1,242.86
-33.84%
IN:RALLIS
Rallis India Limited
209.85
-132.76
-38.75%
IN:SHARDACROP
Sharda Cropchem Ltd.
783.90
-150.48
-16.10%
IN:UPL
UPL Limited
571.00
-136.90
-19.34%
Sumitomo Chemical India Ltd. Corporate Events
Sumitomo Chemical India Shares Q1 FY2026 Investor Presentation Highlighting Stability
Jul 27, 2026
Sumitomo Chemical India Ltd. has submitted an investor presentation detailing its financial results for the quarter ended June 30, 2026, to both BSE and the National Stock Exchange of India. The presentation, described as marking “a year of ...
Sumitomo Chemical India Shares FY26 Results in Investor Presentation
May 27, 2026
Sumitomo Chemical India Ltd. has released an investor presentation detailing its financial results for the quarter and full year ended 31 March 2026. The company has submitted this presentation to both BSE and NSE for disclosure under securities r...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.